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A  B  S  T  R A  C  T  A sensitive and precise method for assaying the water permeability 
response evoked by neurohypophyseal hormones and  their synthetic analogues 
on the isolated urinary  bladder of the  toad  (Bufo marinus L.)  is  described.  The 
method  permits  detection  of 8-arginine-vasotocin  at  concentrations  as  low  as 
10-12M. This sensitivity,  not  achieved heretofore with  this  tissue,  results largely 
from minimizing interference of inhibitory substances by means of an "in vitro 
circulation assembly." The precision of the method derives from a  direct com- 
parison between the cumulative dose-response curve of an agonist of unknown 
potency acting  on  one  hemibladder  and  that  of a  reference compound  acting 
on  the  contralateral  hemibladder.  Crystalline  deamino-oxytocin is  used  as  the 
reference standard  in  this assay. The intrinsic  activity of 2-(O-methyltyrosine)- 
oxytocin, as defined by the maximal response, is  12 %  lower  than  that  of dea- 
mino-oxytocin. All other hormonal peptides investigated have the same intrinsic 
activity as  deamino-oxytocin,  even  5-valine-oxytocin,  in  spite  of its  extremely 
low affinity. A comparison of the potencies of 8-arginine-vasotocin vs. 8-arginine- 
vasopressin,  8-ornithine-vasotocin  vs.  8-ornithine-vasopressin,  8-alanine-oxyto- 
cin  vs.  8-alanine-oxypressin,  and  deamino-8-alanine-oxytocin  vs.  deamino- 
8-alanine-oxypressin suggests that an isoleucine residue  in  position 3  imparts a 
higher specificity for binding of the hormonal peptide molecule to the bladder 
receptor than a  phenylalanine residue in this locus. 
INTRODUCTION 
The mammalian  antidiuretic  hormone, vasopressin, modifies the permeability 
to water  of the  distal  nephron  and  thereby  accelerates  osmotic equilibration 
of the  forming  urine  with  the  renal  interstitial  fluid  (4).  Similarly,  neuro- 
hypophyseal  peptides  increase  the  rate  of water movement  along  an  osmotic 
gradient  across  the  skins  and  bladders  from frogs  and  toads.  In  these  target 
tissues  the  hormone  interacts  with  a  receptor  moiety  in  the  epithelial  cell 
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which in turn modifies the selective permeability of the cell membrane.  One 
approach towards elucidating the mechanism of the initial hormone-receptor 
interaction  is  to  examine  the  contribution  of individual  molecular  features 
of agonists to biological function. Studies of this type, however, have met with 
great difficulties in  toad bladder preparations. 
This  publication  describes  a  sensitive  bioassay  procedure  for determining 
the specific activities of neurohypophyseal hormones and synthetic analogues 
on  the  isolated  urinary  bladder  of the  toad,  BurG marinus. The  extension  of 
this  method to the  study not only of drug-receptor reaction kinetics but  also 
of cumulative  dose-response  relationships  permits  evaluation  of  pharmaco- 
logical concepts such as affinity, intrinsic  activity,  and  antagonism. 
MATERIALS  AND  METHODS 
Male and female toads (BurG marinus) weighing 180 to 250 g used in these experiments 
were kept on moist peat moss.  After the animals had been double pithed, the urinary 
bladders were immediately dissected and placed in Ringer's solution of the following 
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FIGURE  1.  Structure  of 8-arginine-vasotocin.  Numbers  indicate  the  positions  of the 
individual  amino acid residues. 
composition: NaCI  110 mM,  KC1 3  mM,  CaCI2  1 InM, dextrose  1 raM, MgC12  1 raM, 
NaHCOa  3  mM;  tris(hydroxymethyl)aminomethane, HC1  (Trizma  ®)  10  mM  was 
employed as a  buffer and  the pH was  adjusted with NaOH  to 8.4 unless  otherwise 
indicated in the text; the osmotic activity was 242 milliosmols/liter. 
The following hormones and  analogues were employed in  this  study:  8-arginine- 
vasotocin (Fig.  1)  (26), 8-arginine-vasopressin (7), 8-ornithine-vasotocin (17), oxyto- 
cin  (8,  9),  deamino-oxytocin  (10,  16,  22),  2-(0-methyltyrosine)-oxytocin (23,  28), 
8-alanine-oxytocin  (18,  37),  deamino-8-alanine-oxytocin  (37),  8-alanine-oxypressin 
(37),  deamino-8-alanine-oxypressin  (37),  5-valine-oxytocin  (39),  8-ornithine-vaso- 
pressin (17). These synthetic hormonal peptides were prepared in our own laboratories 
and those of the Academy of Science in Czechoslovakia and of Sandoz S.A. in Swit- 
zerland. 
The  compounds  were  assayed  for  avian  vasodepressor  activity according  to  the 
method of Munsick,  Sawyer, and  Van Dyke (29).  In  the fowl bioassay a  four point 
design was used with the usP Posterior Pituitary Standard as a reference. The values 
obtained for the avian vasodepressor activity for the analogues enumerated in Table II 
were in  accordance with  those previously published.  The only exception was  2-(0- 
methyltyrosine-oxytocin, which  possessed  only half the  avian  vasodepressor activity 
reported earlier  (28), perhaps due to inactivation during storage. The potency value 
of 2-(O-methyltyrosine)-oxytocin obtained for the water flux on the toad bladder was 
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bladder preparation were determined  by employing crystalline deamino-oxytocin as 
a  reference standard. 
Preparation of the  Toad Bladder 
~fhe isolated henfibladder is gently stretched over a hollow glass rod of 0.5 cm diameter 
so that  the  mucosal  bladder surface is in contact with  the glass.  A  square knot with 
surgical silk is loosely placed 4.3 cm from the base of the rod. Subsequently the bladder 
is pulled downward  and  secured with a  second knot just above the  broadened  base. 
FIGURE  2.  Experimental 
preparation  for  measuring  the 
permeability  to  water  of  the 
isolated  toad  bladder.  The 
serosal  fluid  is  continuously 
circulated  by  siphoning  hor- 
mone-containing Ringer's fluid 
from a  reservoir at a  controlled 
rate into the  bottom of a  bath 
and  by  suctioning  fluid  in 
excess  of  100  ml  from  the 
surface  of  the  bath.  Bladders, 
mounted  onto  hollow  glass 
tubes and filled with hypotonic 
fluid (mucosal fluid), are placed 
in  a  bath  of  isotonic  fluid, 
vigorously  stirred  by  a  jet  of 
air saturated with water. 
After removal of excess tissue, the bladder is filled with 7 ml of Ringer's fluid which had 
been diluted to }~th strength  (nmcosal fluid). This "sac"  preparation of the  bladder 
is similar to that described by Bentley (3) and it guarantees uniformity of membrane 
surface  area.  Four  to  six  bladders  thus  prepared  were  suspended  in  a  bath  of full 
strength Ringer's solution as detailed in Fig.  2. 
Assay Assembly 
For the water  movement  studies the following assembly was  designed  to assure con- 
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concentration.  As illustrated  in  Fig.  2  the  fluid  bathing  the serosal  (outside)  surface 
of the  bladder is replenished  at a  rate of 6  ml/min with fresh full strength Ringer's 
fluid containing a given hormone concentration. This serosal bath is vigorously stirred 
with air saturated with water and is maintained  at a  constant volume of 100  ml by 
removing bathing fluid at a  rate equal  to the input.  The net  increase in  transmem- 
brane water flow along an osmotic gradient was determined every 30 rain by weighing 
the individual bladder assemblies on a  Sartorius microbalance (type 2303).  Following 
each 30 rain weighing period, the mucosal fluid was replaced with 7 ml of fresh fluid. 
Protocol for Dose-Response Studies 
10  hemibladders  were  filled  with  7  ml  of 1/~th  strength  Ringer's solution  (mucosal 
fluid)  and  incubated  for  120  rain  in  400  ml  of hormone-free full  strength  Ringer's 
solution stirred vigorously with air.  Meanwhile two series of serosal solutions  (500 ml 
for each horinone  concentration)  were prepared,  containing  our standard  deamino- 
oxytoein  and  the  analogue  to  be  tested,  respectively.  The  hormonal  dosages  were 
increased  geometrically  by  a  factor  of 2  starting  from  a  threshold  concentration 
of the  standard  and  analogue.  One  set of five hemibladders  (control)  was  removed 
from  the  hormone-free  incubation  medium  and  placed  into  a  100  ml  aliquot 
of  fresh  full  strength  Ringer's  solution  containing  the  lowest  concentration  of 
deamino-oxytocin, The contralateral set of five hemibladders (experimental) was also 
placed into a  100  ml bath of fresh full strength Ringer's solution  but containing  the 
lowest dose of analogue instead  of standard.  The hormone solutions  in  both control 
and experimental serosal baths were replenished at a  flow rate of 6 ml/min from their 
respective 360  ml reservoirs.  After the second weighing period  (60 rain)  control and 
experimental hemibladders  were  transferred  directly  to fresh serosal  baths  with  the 
next higher concentration of standard and analogue.  Here again, the flow rate of the 
fresh hormone  solutions  from the  reservoirs was  set  at  6  ml/min.  This  transferring 
procedure was repeated until a further geometrical increase in hormone concentration 
failed to yield a  higher response.  At this point  both sets of hemibladders were chal- 
lenged with a  supramaximal dose (approximately 20 times the EDs0)  to test whether 
the maximal response had indeed been reached during  the cumulative dose-response 
experiment. 
RESULTS 
Effect  of a "Circulating"  Serosal Solution  on  the Osmotic Flux of Water 
The  response  of one  set of hemibladders  to  5  X  10 -9 u  oxytocin in  a  serosal 
bath  with  a  flow  rate  of 6  ml/min  (control)  is  compared  with  the  response 
of the  contralateral  set  of hemibladders  to  the  same dose  of hormone  but  in 
a  serosal  bath with  a  flow rate  of 0  ml/min  (experimental)  (Fig.  3).  For the 
first  30  min  period  the  responses  of the  paired  hemibladders  were  of com- 
parable  magnitude,  but  in  subsequent  periods  they  diverged  increasingly, 
i.e.  the  control  bladders  maintained  a  high  level  of response  throughout  the 
time course of the experiment,  in contrast to the experimental bladders which 
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Effect of Hormone  Concentration  on the  Time Course of the Response 
The  response  of bladders  to various concentrations  of oxytocin  (1  ×  10  -7 M, 
5  ×  10  -9 M,  and  1  ×  10 -9 M) was followed for 300 min  (Fig. 4)  without prior 
incubation in hormone-free Ringer's fluid.  In the course of the experiment the 
flow  rate  of  the  hormone-containing  serosal  solution  was  maintained  at  6 
ml/min.  It should  be noted  that  the  optimum  response  to each dose  of hor- 
mone varied not only in magnitude, but also in the rates at which these optima 
were  reached.  Thus with  1  ×  10 -7 M oxytocin the  optimum  of 55.4  mg/min 
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FIOERE 3.  Curve A  (filled  circles),  average rate  of weight  loss of  10  control  hemi- 
bladders exposed  to  5  X  10  -9 M oxytocin; the  serosal  bath had  a  circulation rate  of 
6 ml/min.  Curve B (open circles),  average rate of weight loss of 10 experimental con- 
tralateral hemibladders, exposed  to an identical concentration of hormone; the serosal 
bath had a circulation rate of 0 ml/min. 
had  already been obtained during  the first 30 min interval; with 5  X  10  -9  M 
oxytocin  the  optimum  of 33.2  mg/min  was  recorded  during  the  second  30 
min interval,  and finally, with  1  ×  10 -9 M oxytocin the optimum  of 25.0 mg/ 
min was not reached until the fourth 30 min interval.  Furthermore,  a  correla- 
tion  in  the  rate of fading  of the response to  these various doses of hormone is 
apparent from Fig. 4. While the response of the bladder to 1  ×  10 .7 M oxytocin 
declines rapidly after its maximum  to approximately 50%,  the further decline 
is an extremely gradual one.  In contrast,  the  rate  of fading of the response  to 
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EjSect of Incubation  on Bladder  Reactivity 
Bladders  were  kept  in  hormone-free  Ringer's  solution  vigorously  agitated 
with moist air for increasing periods of time. Subsequently, the bladders were 
challenged  for  30  min  by  transferring  them  into  a  fresh  bath  of Ringer's 
solution containing 2.5  X  10 .9 ta oxytocin. The effect of incubation on the 
reactivity of paired hemibladders was ascertained for 2 hr intervals by com- 
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FIGURE 4.  Hemibladders  exposed  to  serosal  Ringer's  fluid  circulating  at  a  rate  of 
6 ml/min but containing  different doses of oxytocin. Curve A (open circles) shows average 
rate of weight loss of 16 control hemibladders challenged with 1 X  10  -7 M  oxytocin. Curve 
B (filled triangles) and curve C  (filled circles) show average rate of weight loss of experi- 
mental contralateral hemibladders challenged with 5  X  10-gM and 1 X  10  -9 M oxytocin, 
respectively. 
paring bladders which were kept in hormone-free Ringer's solution for: 0 vs. 
120  min;  120 vs.  240  min; and 240 vs.  360  min. The response following the 
360  min incubation period was taken as  100%.  It is apparent from Table  I 
that the reactivity of the bladders increases with time of incubation. 
Time-Dose-Response  Studies 
A  modified cumulative dose-response curve obtained on the toad bladder is 
illustrated  in  Fig.  5.  Bladders  were  challenged  with  increasing  doses  of 
deamino-oxytocin as outlined under the Protocol for Dose-Response Studies. 
The  response  of the  bladders  during  exposure  to  each  hormone  level  was 
followed for two consecutive 30  rain periods.  The study revealed a  stepwise 
increase  of response  with  increasing dosage  of the  agonist.  The  magnitude 
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the  lower dosage  range;  however,  in  the  higher  dosage  range,  the  response 
observed during  the second weighing  period was considerably less than  that 
observed during  the first weighing period. 
TABLE  I 
EFFECT  OF  INCUBATION  TIME  ON 
RESPONSIVENESS  OF  BLADDER  TISSUE  TO 
AN  IDENTICAL  DOSE  OF  OXYTOGIN 
Response to oxytocin 
Time of incubation in  (2.5)< 10  -9 M, pH 8.0) 
hormone-free Ringer's solution  Number of bladders  as % of maximum 
0  3  32 
120  6  47 
240  7  83 
360  4  100 
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FIOURE  5.  Average rate of weight loss of 16 hemibladders incubated in hormone-free 
Ringer's fluid for  120 min. The bladders were then transferred  to a  serosal bath contain- 
hag deamino-oxytocin  with  a  circulation  rate  of 6  ml/min.  The  response  to  each  con- 
centration of agonist was determined for two successive 30 min weighing periods. Bladders 
were then placed directly into a fresh serosal bath containing the next higher concentra- 
tion of deamino-oxytocin,  etc. 
Effect of Theophylline on the Response to Oxytocin 
With  a  set of hemibladders  a  cumulative  dose-response curve was obtained 
for  oxytocin  in  the  presence  of a  0.5  rnM  concentration  of theophylline--a 
concentration  below  the  level  capable  of inducing  hydroosmotic  flux;  with 
the  contralateral  set of hemibladders  a  cumulative  dose-response curve was 472  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  52  •  I968 
obtained  for  oxytocin  alone.  The  concentration  of  oxytocin  required  for 
half-maximal  response  (EDn0)  was 1.29  X  10  -9 w in the absence of theophyl- 
line,  and  1.92  ×  10  -I° M in the presence of theophylline. 
Effect of Hydrogen Ion Concentration on the Response to Oxytocin 
Following  a  2  hr  incubation  period,  bladders  were  exposed  to  a  constant 
concentration  of hormone  but to different hydrogen  ion concentrations  in  a 
serosal bath circulating at 6 ml/min. At 60 rain intervals the pH of the serosal 
bath was raised from an initial  pH of 6.10,  to 6.85,  to  7.15,  to 7.77,  to 8.40. 
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FIouP~ 6.  Cumulative  log-dose-response curves  for  crystalline deamino-oxytocin 
(open  circles),  oxytoein  (open  triangles),  8-arginine-vasotoein  (filled circles),  2-(0- 
methyltyrosine)-oxytocin (filled circles connected by broken lines), 8-deamino-alanine- 
oxypressin  (filled triangles  connected  by broken  lines), 8-ornithine-vasotoein  (open 
squares). Deamino-oxytoein served as a standard  for control hemibladders. Each ana- 
logue was tested in contralateral  experimental  hemibladders  against the  standard  at 
various response levels. 
Throughout  the  experiment  the  oxytocin  concentration  was  kept  constant 
at 5  X  10  -9 w.  It was found that with this stepwise increase in pH from 6.10 
to 8.40,  the response increased from 3.4 to 42.40-/0, 52.50-/0, 89.8°~, and  100°-/o, 
respectively. 
Dose-Response Plots of Neurohypophyseal Hormones and Analogues 
Time-dose-response  curves  of  individual  analogues  and  of  the  standard, 
deamino-oxytocin,  were  obtained  simultaneously  on  contralateral  hemi- 
bladders. The dose-response curves were derived from such modified cumula- 
tive  dose-response  studies  as  illustrated  in  Fig.  5.  The  optimal  response  for 
any given dose of hormone  during  the 60 rain  challenge  period was selected 
for graphing  the log-dose-response plots.  The  maximum  response was deter- 
mined with a final dose amounting to 20 times the EDs0.  For some analogues 
this value was checked by challenging  fresh contralateral  hemibladders  with 
supramaximal  doses of reference  standard  and  unknown.  Fig.  6  shows such ;> 
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dose-response curves obtained for 8-arginine-vasotocin, 8-ornithine-vasotocin, 
oxytocin, deamino-oxytocin, deamino-8-alanine-oxypressin, and 2-(O-methyl- 
tyrosine)-oxytocin. The dose-response curves of all  analogues studied paral- 
leled that of the standard deamino-oxytocin. The curves for several analogues 
were shifted variously to the left of the standard curve: 8-arginine-vasotocin 
dramatically,  8-ornithine-vasotocin  and  8-arginine-vasopressin  moderately, 
and  both  oxytocin  and  8-alanine-oxytocin  slightly.  The  following dose-re- 
sponse curves were displaced to  the right  of the  standard  curve:  the  oxy- 
pressins  (deamino-8-alanine-oxypressin  and  8-alanine-oxypressin)  and 
5-valine-oxytocin markedly,  both  8-ornithine-vasopressin and  2-(O-methyl- 
tyrosine)-oxytocin  moderately,  and  deamino-8-alanine-oxytocin  slightly. 
Differences  in  the  maximum response  for  all  analogues  were  insignificant 
with  the  exception  of  2-(O-methyltyrosine)-oxytocin,  which  exhibited  a 
maximum of only 88% of that of the standard. 
The activities of these peptidyl hormones in the toad bladder hydroosmotic 
assay are compared in Table II with the activities of these compounds in the 
fowl  vasodepressor, rat  uterotonic,  rat  antidiuretic,  rat  pressor,  and  rabbit 
milk ejection bioassays. The toad bladder hydroosmotic activity of the com- 
pounds is expressed in two ways: (a) in terms of the concentration of analogue 
required to evoke a  half-maximal response, i.e.  the ED60, which reflects  an 
average sensitivity of the particular bladder preparation;  (b)  in terms of the 
potency  (expressed  as  a  per  cent  of the  potency  of the  deamino-oxytocin 
standard) as derived from the ED60 value measured on one hemibladder and 
compared directly to the ED~0 value measured for the standard on the contra- 
lateral  hemibladder, which  makes  the  potencies  independent of variations 
in sensitivity of bladders from different toads. 
DISCUSSION 
Several procedures have been employed for determining the relative potencies 
of neurohypophyseal hormones and  analogues with respect to  the effect of 
these agents on the permeability to water of the isolated urinary bladder of 
the toad, Burg marinus (3,  11, 32). However, it is germane to an understanding 
of structure-activity relationships, that parameters, such as intrinsic activity, 
affinity, synergism, and antagonism, be evaluated by means of dose-response 
studies. In addition, such investigations should be complemented by a kinetic 
analysis of factors influencing the response pattern of the receptor tissues to a 
given challenge. It is apparent that the study of the potency, type of action, 
and pharmacokinetic properties of hormones requires not only a  specific and 
sensitive  preparation,  but  also  one  in  which  the  response  can  be  readily 
quantitated, and in which several doses of an unknown can be tested against 
a  standard. The widely used sac preparation of the isolated toad bladder (3) 
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emerges from the observation that the sensitivity of this membrane changes 
with time (11,  13, 35)  and with the history of transmembrane hydroosmotic 
flux  (12),  circumstances which have made dose-response studies  (especially 
cumulative dose-response studies) unrewarding in the past. 
In this context it may be recalled that the bladder tissue releases into the 
serosal  solution an inhibitory substance of unknown structure  (13,  24)  and 
that  this  antagonist  was  subsequently  isolated  in  increased  yields  from 
whole bladder homogenates (25). In addition, a  peptidase, which completely 
abolishes the activity of 8-1ysine-vasopressin, was obtained from such homoge- 
nares (5). It has been an arduous task to discern the interdependence of these 
inhibitory substances and to determine their relative contribution at various 
loci--intracellular  and  extracellular--to  alterations  in  membrane  permea- 
bility. 
In approaching this problem we devised methods which entail the physical 
removal of inhibitory substances which constantly escape from the tissue into 
the  serosal  bath.  This  was  accomplished with  an  assay  assembly  (Fig.  2) 
consisting in essence of an in vitro circulation which continuously bathes the 
membrane in fresh serosal solution and maintains a  constant concentration 
of hormone. Such a  method made it possible to retain the response to, 5  X 
10  -9 M oxytocin at a  near constant level for a  prolonged period of time (Fig. 
3,  curve A).  The experiment shows that  inhibitory factors which diminish 
the response in the uncirculated preparation  (Fig.  3, curve B) can be physi- 
cally removed. 
The  finding that  a  constant response plateau could be  maintained by  a 
circulating  serosal  bath  (Fig.  3,  curve  A)  suggested that  the  self-limiting 
character of the response to 5  X  10  -9 ~  oxytocin in the uncirculated prepara- 
tion  (Fig.  3, curve B) was due to the accumulation of inhibitory substances. 
In  an  effort  to  discern  factors  other  than  inhibitory  substances  affecting 
bladder reactivity, we studied with the circulation assembly the time course 
of the response to grossly different doses of hormone. Curve A in Fig. 4 shows 
that the initial response following a supramaximal dose of oxytocin cannot be 
sustained; in fact,  the immediate rise to a  maximum is followed by a  rapid 
decline.  In this particular  experiment the response diminished by  approxi- 
mately 50%  and  slowly faded thereafter.  The  fact  that  an  increase  in  the 
circulation rate of the bath from 6 to 25 ml/min did not influence the nature 
of the  response  militates  against  the  possibility  that  the  decline  in  tissue 
sensitivity was caused by an increased rate in the release of inhibitory sub- 
stances into the serosal medium. When the bladders were challenged with an 
intermediate dose of hormone (Fig. 4, curve B), the pattern of response was 
characterized by a  slightly delayed optimum followed by a  gradual decline 
similar to that shown in curve A  after the half-maximum permeability level 
had been reached.  If the bladders were stimulated by an even lower dose of 476  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  52  •  I968 
hormone (Fig. 4, curve C), the most striking difference in the response pattern 
was not the phase of decline, but rather the rate at which the optimum was 
reached. Thus the sensitivity of the bladder is affected by opposing factors 
and their relative influence will determine the reactivity of the bladder. The 
magnitude of the factor which tends to diminish reactivity is related to the 
intensity  and  duration  of prior  stimulation.  The  magnitude  of the  other 
factor--the tendency to  enhance tissue  sensitivity--is dependent upon  the 
duration of exposure of bladders to hormone-free Ringer's fluid  (Table  I). 
These considerations proved useful in following the change in bladder reac- 
tivity during  the  course of a  cumulative dose-response study in  that  only 
those  responses  in  which the  tissue  sensitivity did  not  change appreciably 
during two successive 30 min periods of exposure to a given hormone concen- 
tration were considered reliable  (e.g.,  the first four concentration levels of 
hormone in Fig.  5.). 1 We found usually that changes in  bladder reactivity 
were minimal below the  70% response level--a response range that is well 
within the limits required for affinity determinations. Above the 70% response 
level the reactivity to a given dose of hormone was less consistent; thus it was 
not  always  possible  to  ascertain  the  minimal  dose  required  to  evoke  the 
maximal response. In order to test whether the maximum response had indeed 
been reached during the cumulative dose-response experiment, the bladders 
were stimulated with a final dose at least 90 times greater than the EDs0. In 
instances in which a  discrepancy in sensitivity between contralateral hemi- 
bladders  were  suspected  because  of differences in  duration  and  extent  of 
previous  hydroosmotic fluxes,  the  maximal responses were tested  by chal- 
lenging fresh contralateral hemibladders with supramaximal doses of reference 
standard  and  unknown; identity of the maximal response to  the  analogue 
with the maximal response to the standard signified identical intrinsic activity. 
In  order to  enhance tissue  sensitivity prior  to  challenge with  the lowest 
hormone concentration, bladders were incubated in  hormone-free Ringer's 
solution  for  a  period  of 2  hr.  This  time  interval was chosen for  practical 
purposes to assure the completion of a cumulative dose-response study within 
a  reasonable time span--although a  longer incubation period was found to 
further enhance bladder sensitivity. Moreover, we established that a stepwise 
increase in serosal pH  from 6. I-8.4 was paralleled by a  graded increase in 
the response of the tissue to a constant concentration of oxytocin. The finding 
of a pH optimum (8.4)  of membrane reactivity to oxytocin confirms previous 
observations by Gulyassy and Edelman (14,  15).  In addition, we recorded a 
1 In  instances when only limited  amounts of hormone  are  available,  a  cumulative dose-response 
curve  may also  be obtained,  although  the change  in  tissue sensitivity cannot be  ascertained,  by 
following the response to each dose for only one 30 rain period. It should be noted that the cumula- 
tive dose-response curve in  Fig.  5  bears  striking  resemblance to  the theoretical  cumulative dose- 
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6.7-fold increase in the reactivity of the bladder to oxytocin in the presence 
of a  subthreshold concentration of theophyUine--an effect reported qualita- 
tively by Orloff and Handler  (30). These pH and theophylline experiments 
show that this assay method can quantitate such parameters as synergism and 
antagonism. 
The  sensitivity of the  toad  bladder  preparation  is  reflected  in  the  dose 
required  to evoke a  half-maximal response  (ED~0). However,  the accuracy 
of this bioassay method hinges upon a  direct comparison of the  ED60 value 
of an analogue, measured with one hemibladder, with the  ED60 value of a 
standard,  measured  with  the  contralateral  hemibladder.  The  precision  of 
this method, therefore, depends upon sensitivity differences between contra- 
lateral hemibladders of the same toad, and not--as in previous toad bladder 
bioassays  (see reference 32)--upon substantial fluctuations in sensitivity be- 
tween bladders from different toads. It should be pointed out that the expres- 
sion of hydroosmotic activity of a hormone analogue in terms of concentration 
(EDs0  values from noncontralateral  hemibladders) is less precise than in terms 
of potency (derived from EDs0  values from contralateral  hemibladders). This 
difference is illustrated in the following example: The potency of 8-ornithine- 
vasotoein is 486 with a  standard error of the mean (sEu) of ±16  (Table II). 
This  value  was  obtained  by  comparing  the  ED~0 of 8-ornithine-vasotocin 
with  the  ED60 of deamino-oxytocin in  contralateral  hemibladders.  Subse- 
quently the results from several  such determinations were averaged.  If,  on 
the other hand, the potency of 8-ornithine-vasotocin was calculated from the 
same  ED~0 values, but from randomly chosen sets of noncontralateral hemi- 
bladders, a  potency value of 920  ±  80 was obtained. 
In a  preliminary study with this new assay procedure we have gathered 
data  to  assess  the  effect  upon  affinity  and  intrinsic  activity  of structural 
changes in neurohypophyseal hormones. In particular we investigated a series 
of selected hormone peptides exemplifying such varied groups as the oxytocins 
(with an isoleueine residue in position 3 and a  neutral amino acid residue in 
position 8),  vasotocins  (with an isoleucine residue in position 3  and a  basic 
amino acid residue in position 8), oxypressins (with a  phenylalanine residue 
in position 3 and a neutral amino acid residue in position 8), and vasopressins 
(with a phenylalanine residue in position 3 and a basic amino acid residue in 
position 8). The biological activities of the neurohypophyseal hormones and 
their  analogues  were  compared  with  that  of crystalline  deamino-oxytocin 
following an earlier suggestion of Jarvis  and du Vigneaud  (22).  The use of 
deamino-oxytocin as  a  reference  for  the  toad  bladder  hydroosmotic assay 
offers several advantages: (a) it is a homogeneous material of known structure 
readily prepared by solid phase synthesis (36); (b) it is obtained in crystalline 
form and hence yields material with reproducible biological activity irrespec- 
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and less readily inactivated in solution than 8-arginine-vasopressin, 8-1ysine- 
vasopressin, or 8-arginine-vasotocin; (d)  it occupies an intermediate position 
in the potency spectrum of neurohypophyseal peptides in the toad bladder. 
As shown in Fig.  6  and Table  II  all compounds investigated, except for 
2-(O-methyltyrosine)-oxytocin, possessed essentially the same intrinsic activ- 
ity. However, the affinity for the toad Madder receptor varied markedly with 
different analogues. For example 8-arginine-vasotocin, a  natural amphibian 
neurohypophyseal hormone, possessed the highest affinity,  332-fold  greater 
than that of our reference standard  (crystalline deamino-oxytocin). In  this 
context it may be recalled that Jard and Morel (19-21) in their elegant study 
of agonism and antagonism of neurohypophyseal hormones in the frog kidney 
(Rana esculenta L.)  were able  to elicit an  antidiuretic response with  10  -11 M 
8-arginine-vasotocin,  a  dosage  which approximates that found to be effec- 
tive in  our present in vitro study with the toad bladder. 
In  an  attempt to  correlate  structural  modifications of neurohypophyseal 
hormones with changes in membrane permeability to water,  we focused on 
amino acid residue substitutions in positions 3  and 8--loci which were par- 
ticularly susceptible to mutational alterations in the course of evolution (1, 33). 
The conversion of 8-arginine-vasotocin to 8-arginine-vasopressin brings about 
a  24-fold  decrease  in  hormone  affinity.  An  analogous  replacement  in  8- 
ornithine-vasotocin resulted in a 35-fold decrease in activity. We next explored 
the effect on transmembrane hydroosmotic flux of replacing the basic amino 
acid residue in 8-arginine-vasotocin by neutral instead of basic  amino acid 
residues.  Thus we  determined the  potencies of oxytocin  and  of 8-alanine- 
oxytocin,  an  analogue in which the leucine moiety of oxytocin is  replaced 
with an alanine moiety. Both compounds exhibited an activity of comparable 
magnitude.  Furthermore,  modification in  position  3  of 8-alanine-oxytocin 
by replacing the isoleucine moiety with a phenylalanine moiety--an alteration 
analogous  to  that  described  for  the  8-arginine  and  8-ornithine  analogues 
(see  above)--results  in  8-alanine-oxypressin,  a  molecule  exhibiting  a  low 
affinity for the bladder receptor. 
The structure-activity relationship of this series  of analogues with  amino 
acid replacements in position 3  presents a  pattern which shows that an iso- 
leucine side chain in position 3  (as compared with a phenylalanine side chain 
in this locus) imparts a higher specificity for binding of the hormone molecule 
to the bladder receptor. A comparison of our results with those of Rasmussen 
et al.  (32), the most extensive attempt to date to defme the contribution of a 
particular  group  in  the  natural  hormone  to  biological  activity  in  a  toad 
bladder system, reveals that our present assay method is 100 times as sensitive 
as that employed in their study. 
Previously it  was  shown  (38)  that  structural  alterations  in  position 5  of 
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in the avian vasodepressor, rat pressor, rat uterus, and rat antidiuretic assays. 
A representative of this group is 5-valine-oxytocin (39), an analogue in which 
a  valine residue replaces the asparagine residue of oxytocin. The potency of 
this compound in all assays studied was so low that a test for intrinsic activity 
has been heretofore precluded by excessive material requirements. Hence it 
appeared desirable to study 5-valine-oxytocin with respect to its affinity and 
intrinsic activity in the toad bladder assay. It is of interest, that this analogue 
possesses,  in spite of an extremely low affinity, an intrinsic activity equal to 
that of deamino-oxytocin. 
In  view  of the  difficulties  previously  encountered  in  characterizing  the 
amphibian hydroosmotic activity of 2-(O-methyltyrosine)-oxytocin (32),  we 
reinvestigated this problem and established that the intrinsic activity of this 
analogue was only 88%  and its  affinity 6.8% that of the standard.  Also in 
other assay preparations,  viz.  uterotonic assays  (27),  a  diminished maximal 
response in cumulative dose studies was reported previously for this compound 
under a  variety of experimental  conditions.  Furthermore,  a  comparison  of 
the  hormonal  octapeptides  with  their  corresponding  deamino-analogues 
indicates that the replacement of the free amino group in position  1 by hy- 
drogen lowers the potency of these analogues in the toad bladder preparation. 
The opposite effect of this replacement--namely, enhancement of potency-- 
has  been  abundantly  demonstrated  in  the  rat  antidiuretic,  rat  uterotonic, 
and fowl vasodepressor assay systems (6, 34). 
In  summary,  a  systematic  investigation  of  factors  influencing  bladder 
reactivity has led to the development of a  convenient, sensitive, and precise 
assay method for measuring transmembrane hydroosmotic flux. This method 
was used to gain insight into drug-receptor interactions by evaluating dose- 
response  and  time-response  relationships.  In  this  study  we  have  probed 
physiological  properties  of  the  receptor  elements  of  a  neurohypophyseal 
hormonal  target  tissue  employing  as  agonists  a  series  of  analogues,  with 
chemical modifications in nonpolar, polar,  and formally charged groupings. 
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